Srinivasa Reddy Bonam | Immunology | Young Scientist Award

Published on 16/09/202516/09/2025 by Young Scientists Awards

Dr. Srinivasa Reddy Bonam | Immunology | Young Scientist Award

Senior Scientist | Indian Institute of Chemical Technology | India

Dr. Srinivasa Reddy Bonam is a distinguished scientist specializing in immunology, vaccine development, and pharmacology, with a significant research impact demonstrated by over 4,892 citations from 4,654 documents and an h-index of 29. He currently serves as an Assistant Professor at the Academy of Scientific and Innovative Research (AcSIR) and Senior Scientist at CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India. His extensive research experience spans advanced vaccine design, mRNA therapeutics, immunomodulators, and host-pathogen interactions. Dr. Bonam completed his Ph.D. at CSIR-IICT, Hyderabad, focusing on the immunopharmacological evaluation of novel glycopeptides and glycolipids as vaccine adjuvants and immunomodulators. His doctoral research led to the identification of multiple lead adjuvant candidates, with one licensed by Bharat Biotech International Ltd for emerging vaccines. After his Ph.D., he pursued postdoctoral research in Europe and the USA, contributing to the development of therapeutic peptides for autoimmune diseases at the University of Strasbourg, innovative immune regulation mechanisms in fungal infections and COVID-19 at INSERM Paris, and designing novel mRNA vaccines at the University of Texas Medical Branch (UTMB) in collaboration with Prof. Drew Weissman’s lab. Dr. Bonam has received honors including the Marie Curie Fellowship (self-denied), Outstanding Reviewer Awards from MDPI journals, and the Distinguished Alumni Award from CIPS. He serves as Editor-in-Chief of Advances in Pharmacology and Pharmacy, editorial board member of multiple journals, and peer reviewer for over 90 scientific journals. His pioneering contributions include patents on novel vaccine adjuvants and the development of Uttroside, a saponin-based vaccine adjuvant licensed to Bharat Biotech International Ltd. Driven by a commitment to next-generation vaccines and therapeutic strategies, Dr. Bonam continues to address emerging global health challenges through his high-impact research.

Profile: Scopus

Featured Publications

Alameh, M.-G., Semon, A., Hu, H., Bonam, S. R., Maslanka, J. R., Weissman, D., & Zackular, J. P. (2024). A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection. Science, 386(6717), 69–75.

Bonam, S. R., Hazell, N. C., Mathew, M. J., Liang, Y., Zhang, X., Wei, Z., Alameh, M.-G., Weissman, D., & Hu, H. (2024). Innate and adaptive immune parameters following mRNA vaccination in mice. Vaccines, 12(5), 543.

Ye, Z., Bonam, S. R., McKay, L. G. A., Plante, J. A., Walker, J., Zhao, Y., Huang, C., … Hu, H. (2023). Monovalent SARS-CoV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. Proceedings of the National Academy of Sciences, 120(52), e2311752120.
Bonam, S. R., Platenburg, P. P., & Bayry, J. (2022). Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen-presenting cells. Frontiers in Immunology, 13, 7738.
Hajnik, R. L., Plante, J. A., Liang, Y., Alameh, M.-G., Tang, J., Bonam, S. R., … Hu, H. (2022). Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models. Science Translational Medicine, 14, eabq1945.

Muhammad Azeem | Immunology | Best Researcher Award

Published on 29/08/202529/08/2025 by Young Scientists Awards

Dr. Muhammad Azeem | Immunology | Best Researcher Award

University Hospital Wuerzburg | Germany

Muhammad Azeem is a molecular immuno-oncology researcher with expertise in tumor immunology, bone disease, and drug development. Currently a postdoctoral researcher at the University Hospital Würzburg, he focuses on identifying early diagnostic markers of myeloma bone disease and exploring novel drug combinations for treatment. Azeem has a strong background in molecular biology, 3D cell culture systems, and animal modeling, integrating in vitro assays with transcriptome profiling to advance precision medicine. His academic and professional journey spans veterinary medicine, immunology, and translational oncology research, making him a versatile scientist with expertise in molecular techniques, bioinformatics, and advanced cell-based models. He has actively contributed to high-impact publications, organized scientific meetings, and collaborated with interdisciplinary teams on cutting-edge cancer research. With a strong passion for leadership and innovation, Azeem aspires to lead research teams and drive advancements in therapeutic strategies. His career demonstrates dedication to bridging fundamental science with clinical applications in oncology.

Profile

Google Scholar

Education

Muhammad Azeem educational journey reflects his deep commitment to biomedical sciences and translational research. He earned a Doctor of Veterinary Medicine degree from the University of Veterinary and Animal Sciences in Lahore, where he developed strong foundations in animal health and disease mechanisms. He further pursued a Master’s degree in Biology from the Lahore University of Management Sciences, gaining extensive training in molecular biology, immunology, and laboratory research techniques. Building upon this, Azeem completed his PhD in Immunology at the Graduate School of Life Sciences, Julius Maximilians University of Würzburg. His doctoral work focused on immune regulation, contact hypersensitivity models, and the genetic and molecular pathways controlling T-cell responses. During his PhD, he gained hands-on expertise in transgenic mouse models, molecular cloning, protein expression, flow cytometry, and qRT-PCR. This combination of veterinary, biological, and immunological training provides him with an interdisciplinary perspective that bridges animal research, cellular modeling, and human disease studies.

Experience

Muhammad Azeem professional experience spans veterinary research, molecular biology, and immuno-oncology. He began his career at the Veterinary Research Institute in Lahore, where he worked on serological and molecular diagnostics for diseases affecting livestock, such as brucellosis and foot-and-mouth disease, and conducted epidemiological screenings of avian species. Transitioning to academic research, he joined the University Hospital Würzburg, where he completed his doctoral studies on immune regulation and T-cell development using animal models. As a postdoctoral researcher, Azeem specializes in developing advanced 3D cell culture models for studying tumor-bone interactions and identifying early markers of myeloma bone disease. He supervises undergraduate and master’s students, manages laboratory operations, and contributes to grant writing and scientific publications. Azeem has also led collaborations involving transcriptomic profiling and RNA sequencing, combining experimental and computational expertise. His organizational skills extend to planning large-scale symposia and research meetings, reflecting a career dedicated to advancing translational cancer research.

Awards and Honors

Muhammad Azeem has been recognized for his contributions to cancer and immunology research through multiple awards and active participation in scientific events. He won the Best Poster Prize at the Annual DGHO Meeting in Basel for his work on multiple myeloma and previously earned a Second Best Poster Award at the EUREKA International Symposium. Azeem has been invited to deliver talks and present his research at leading conferences, including the Signal Transduction Meeting, IZKF Würzburg Retreat, and Annual T-Cell Meeting. He has also presented his findings at international symposia and workshops, gaining recognition for his work on immune signaling and disease modeling. His leadership roles include organizing international scientific events such as the EUREKA Symposium, which hosted hundreds of participants, and coordinating annual meetings under the DFG μBone consortium. These achievements demonstrate his growing influence in immuno-oncology and his ability to contribute to both research excellence and scientific community engagement.

Research Focus

Muhammad Azeem research focuses on molecular immuno-oncology, with a particular emphasis on understanding and treating myeloma bone disease. His work integrates animal models, transcriptome profiling, and advanced 3D cell culture systems to identify early diagnostic markers and test innovative therapeutic strategies. Azeem is passionate about combining in vitro and in vivo approaches to better model tumor microenvironments and explore novel drug combinations. His research interests span immune cell signaling, T-cell development, cytokine regulation, and the mechanobiology of bone-tumor interactions. He has contributed to projects investigating immune regulation in skin and bone diseases, as well as studies on cancer therapeutics and centrosome biology. His interdisciplinary expertise bridges veterinary science, molecular biology, and oncology, enabling him to approach disease modeling and drug development holistically. Azeem’s long-term vision is to lead a research group dedicated to translating basic science into clinical solutions, advancing precision medicine and immunotherapy in cancer treatment.

Publications

Title: Current insights into immunology and novel therapeutics of atopic dermatitis
Year: 2021
Citations: 89

Title: T cells control chemokine secretion by keratinocytes
Year: 2019
Citations: 35

Title: Intricate relationship between adaptive and innate immune system in allergic contact dermatitis
Year: 2020
Citations: 27

Title: A 3D bioreactor model to study osteocyte differentiation and mechanobiology under perfusion and compressive mechanical loading
Year: 2024
Citations: 5

Title: NFAT5 controls the Integrity of Epidermis
Year: 2021
Citations: 5

Conclusion

Muhammad Azeem is a highly deserving candidate for the Best Researcher Award, with a strong foundation of impactful publications, innovative research methodologies, and demonstrated leadership in both research and scientific event organization. His contributions to understanding myeloma pathogenesis, immune regulation, and therapeutic strategies position him as a rising star in immuno-oncology. With further emphasis on independent research leadership and broader collaborations, he is poised to become a leading figure in his field.

Anurag Singh | Immunology | Young Scientist Award

Published on 17/04/202517/04/2025 by Young Scientists Awards

Mr. Anurag Singh | Immunology | Young Scientist Award

Anurag Singh is an emerging researcher in virology and immunology, currently pursuing his Ph.D. at the All India Institute of Medical Sciences (AIIMS), New Delhi. A Gold Medalist in M.Sc. Virology from ICMR-National Institute of Virology, Pune, and a top performer in B.Sc. (H) Microbiology from the University of Delhi, his academic journey is marked by excellence. With a strong inclination toward infectious diseases, he has contributed to multiple high-impact publications and scientific book chapters. He has been actively involved in various research projects addressing SARS-CoV-2, antimicrobial resistance, and mosquito-borne diseases. His technical expertise includes flow cytometry, PCR, ELISA, and virus culture techniques. A DST-INSPIRE and CSIR-JRF awardee, Anurag has presented his work at both national and international platforms. Beyond the lab, he has taken up leadership roles and actively engages in public health initiatives like HPV vaccination awareness. His passion lies in bridging basic science with translational medical research.

Profile

Scholar

🎓 Education

Anurag Singh holds an impressive academic record in life sciences and biomedical research. He is currently pursuing a Ph.D. at AIIMS, New Delhi (2023–Present). He earned an M.Sc. in Virology from ICMR-National Institute of Virology (2021–2023), graduating with a stellar CGPA of 9.85 and was awarded a Gold Medal for academic excellence. Prior to that, he completed a B.Sc. (Hons.) in Microbiology from Ram Lal Anand College, University of Delhi (2018–2021) with a CGPA of 9.419, ranking among the top performers. His school education was also marked by distinction, with an 85.4% in AISSCE (2016) and a perfect CGPA of 10 in AISSE (2014), both under CBSE. He has supplemented his academic training with certifications in flow cytometry, HIV diagnostics, epidemiology, bioinformatics, and ethical research practices from institutions like Johns Hopkins University and University of Toronto, strengthening his scientific and analytical foundations.

💼 Experience

Anurag Singh has accumulated rich research experience across premier institutions. Currently, he is a Ph.D. scholar at AIIMS, New Delhi (Oct 2023–Present), working on immunopathology and microbiome research. During his M.Sc., he conducted a dissertation on dengue virus detection in Aedes mosquitoes at ICMR-NIV, Pune. Earlier, he led two undergraduate research projects at the University of Delhi: one on drug repurposing against MRSA (18 months) and another on in silico drug intervention for SARS-CoV-2 (12 months). He also interned at Bokaro General Hospital under a microbiology MD, gaining clinical lab experience. Anurag has presented at international and national conferences and published multiple peer-reviewed articles. He is proficient in molecular biology, cell culture, serological assays, and viral diagnostics. Additionally, he has served as President and Secretary of his college microbiology society, coordinated scientific events, and led public health initiatives, showcasing both academic and leadership skills.

🏅 Awards and Honors

Anurag Singh is the recipient of several prestigious awards for academic and research excellence. He is a DST-INSPIRE and Joint CSIR-UGC Fellow, and ranked 91st in the CSIR-NET 2022 exam. He received a Gold Medal from ICMR-NIV for topping his M.Sc. Virology program (2021–2023). At the undergraduate level, he won the Dr. D.K. Pabby Best Student Award (Sciences, 2022) and an Academic Excellence Award (2019–20) from RLAC, University of Delhi. His poster titled “Bacillus coagulans ameliorates Immunopathology of Osteoarthritis” won Best Poster Presentation at the IABS 2025 Conference (AIIMS Bhopal). He has also received appreciation at AIIMS Research Day (2024), and secured second position in a poster competition on avian virus immunization. Additionally, he earned certificates of merit for innovative ideas and has coordinated outreach and awareness campaigns. These accolades highlight his commitment to scientific inquiry, leadership, and community engagement.

🔬 Research Focus

Anurag Singh’s research centers on infectious diseases, immunopathology, and translational virology. He is currently exploring the role of probiotics and neutrophils in inflammatory conditions like ARDS and osteoarthritis. His doctoral work at AIIMS delves into microbiome-host interactions in bone immunology. In past projects, he has investigated dengue virus surveillance in urban mosquitoes and antimicrobial resistance in MRSA using repurposed drugs. He has also contributed to computational biology, evaluating SARS-CoV-2 therapeutics using in silico approaches. His technical proficiencies span live virus handling, PCR, sequencing, ELISA, flow cytometry, and tissue culture. Through his publications and book chapters, he has addressed topics ranging from soil microbes and sustainable development to COVID-19 vaccines and heterologous immunity. Anurag aims to bridge computational biology with experimental virology to develop targeted interventions for viral and immune-related disorders. His interdisciplinary approach combines bench science with bioinformatics, public health insights, and therapeutic innovation.

📝 Conclusion

Anurag Singh is an exceptionally promising young scientist with a commendable academic record, significant research contributions, and clear leadership in both science and community health initiatives. His current Ph.D. training at AIIMS New Delhi, India’s premier medical research institution, adds substantial weight to his trajectory. Given his achievements at such an early career stage, he is highly suitable for the Young Scientist Award.

Publication

Title: SARS-CoV-2 Therapeutics: How Far Do We Stand from a Remedy?
Year: 2021
Authors: A. Singh, V. Gupta

Title: Lactobacillus rhamnosus (LR) Ameliorates Pulmonary and Extrapulmonary Acute Respiratory Distress Syndrome (ARDS) via Targeting Neutrophils
Year: 2024
Authors: L. Sapra, C. Saini, S. Das, P.K. Mishra, A. Singh, A.R. Mridha, P.K. Yadav, …

Title: In Silico Evaluation of Potential Intervention Against SARS-CoV-2 RNA-dependent RNA Polymerase
Year: 2023
Authors: S. Kapoor, A. Singh, V. Gupta

Title: Heterologous Protection to COVID-19 with BCG Vaccine: Deciphering the Reality Using Meta-Analysis Approach
Year: Not specified (but likely around 2021–2024 based on context)
Authors: A. Singh, L. Gupta, V. Gupta

Yǒng zhāng | Immunology | Best Researcher Award

Published on 13/08/202413/08/2024 by Young Scientists Awards

Assoc Prof Dr. Yǒng zhāng | Immunology | Best Researcher Award

Assoc Prof Dr at Jilin University, China

Dr. Yong Zhang is an Associate Professor at the School of Life Sciences, Jilin University, China. He has been with Jilin University since 2010, progressing from a Post-Doc to Lecturer, and now, Associate Professor. Dr. Zhang earned his Ph.D. in Pharmacy from Shenyang Pharmaceutical University and had the opportunity to be a Visiting Ph.D. Student at the University of East Anglia, UK. His research focuses on pharmaceutical sciences and molecular biology, contributing significantly to fields like immunology, drug delivery systems, and vaccine development. Dr. Zhang has published extensively in peer-reviewed journals, with notable works on immune responses and drug solubility enhancement.

Profile

Scopus

Orcid

🎓 Education

PhD in Pharmacy (2003-2009) Shenyang Pharmaceutical University, Shenyang, Liaoning, CN Yong Zhang earned his PhD from the School of Pharmacy at Shenyang Pharmaceutical University, deepening his expertise in pharmaceutical sciences. Visiting PhD Student (2008-2009)
University of East Anglia, Norwich, Norfolk, GB During his PhD, Yong Zhang enriched his research experience at the University of East Anglia, focusing on advanced pharmaceutical studies.. BSc in Pharmacy (1998-2003) Shenyang Pharmaceutical University, Shenyang, Liaoning, CN
Yong Zhang completed his Bachelor’s degree in Pharmacy, laying the foundation for his future academic and professional pursuits in pharmaceutical sciences.

🧑‍🏫 Employment

Associate Professor (2017-Present) School of Life Sciences, Jilin University, Changchun, Jilin, CN Yong Zhang has been serving as an Associate Professor, contributing to the academic growth and research advancements in life sciences.. Lecturer (2012-2017) School of Life Sciences, Jilin University, Changchun, Jilin, CN Prior to his current role, Yong Zhang worked as a Lecturer, where he played a pivotal role in teaching and guiding students in life sciences. Post Doc (2010-2012) School of Life Sciences, Jilin University, Changchun, Jilin, CN Yong Zhang conducted postdoctoral research, focusing on cutting-edge life sciences projects and innovations.

📚 Publications

Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice
- Authors: Dongdong Li, Lijun Bian, Lili Cui, Jingying Zhou, Gaotian Li, Xiaoyan Zhao, Liao Xing, Jiaxing Cui, Bo Sun, Chunlai Jiang, Wei Kong, Yong Zhang*, Yan Chen*
- Journal: International Journal of Nanomedicine
- Publication Year: 2024
- Volume: 19
- Pages: 8029–8042

Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice
- Authors: H Zhao, P Li, L Bian, W Zhang, C Jiang, Y Chen*, W Kong, Y Zhang*
- Journal: International Journal of Molecular Sciences
- Publication Year: 2023
- Volume: 24
- Issue: 17
- Article ID: 13587

Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
- Authors: L Bian, Y Zheng, X Guo, D Li, J Zhou, L Jing, Y Chen, J Lu, K Zhang, C Jiang*, Y Zhang*, W Kong
- Journal: Frontiers in Immunology
- Publication Year: 2022
- Volume: 13
- Article ID: 938598

Immune Response of C57BL/6J Mice to Herpes Zoster Subunit Vaccines Formulated with Nanoemulsion-Based and Liposome-Based Adjuvants
- Authors: L He, B Sun, Y Guo, K Yan, D Liu, Y Zang, C Jiang*, Y Zhang*, W Kong
- Journal: International Immunopharmacology
- Publication Year: 2021
- Volume: 101
- Article ID: 108216

Respiratory Syncytial Virus F Subunit Vaccine with AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice
- Authors: Y Zheng, L Bian, H Zhao, Y Liu, J Lu, D Liu, K Zhang, Y Song, Y Luo, C Jiang*, Yan Chen, Y Zhang*, W Kong
- Journal: Frontiers in Immunology
- Publication Year: 2020
- Volume: 11
- Article ID: 526965

The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
- Authors: Li F, Chen Y, Liu S, Pan X, Liu Y, Zhao H, Yin X, Yu C, Kong W, Zhang Y*
- Journal: International Journal of Nanomedicine
- Publication Year: 2019
- Volume: 14
- Pages: 9917-9928

Muhammad Khurram Tufail | Immunology | Young Scientist Award

Published on 09/02/202409/02/2024 by Young Scientists Awards

Dr. Muhammad Khurram Tufail | Immunology | Young Scientist Award

Professional Summary 🌟

Experienced and self-motivated researcher with expertise in polymer synthesis and chemically stable solid electrolyte materials for next-generation all-solid-state Lithium batteries. Proven background in inorganic materials synthesis, characterization, and electrochemical testing, focused on enhancing the efficiency and safety of next-generation solid batteries (Li-S, Li-ion, LiSeS2). Collaborative team player with a track record of interdisciplinary collaborations, including the use of machine learning (ML) approaches and basic theoretical calculations by DFT.

Professional Profiles

Orcid Profile

🎓 Education

Ph.D. in Chemistry (July, 2021): Beijing Institute of Technology, Beijing, China. Specialization: Electrochemistry, Grade: A. Thesis Title: Design Air-stable Sulfide-based Superionic Conductors for All-solid-state Lithium-Sulfur Batteries. M.Phil. in Chemistry (Nov, 2016): H.E.J Research Institute of Chemistry, ICCBS, University of Karachi, Pakistan. Specialization: Polymer Chemistry, Grade: A. Thesis Title: Synthesis and meticulous molecular characterization of amphiphilic block copolymer constituting PEO and PMMA. M.Sc. in Chemistry (Sept, 2013): The Islamia University of Bahawalpur, Bahawalpur, Pakistan. Specialization: Analytical Chemistry, Grade: B.

💼 Work Experience

Postdoctoral Researcher (Sept. 2021 – Present): College of Materials and Physics, Qingdao University, Qingdao, China. Responsibilities: Working on the project “Development of solid electrolytes (Solid, oxides) for All-solid-state lithium batteries.” Designing research funding projects. Mentoring research fellows. Visiting Faculty Member (Jan. 2023 – June 2023): Institute of Chemistry, The Islamia University of Bahawalpur, Pakistan. Responsibilities: Remotely teaching Materials and Chemistry courses (M.S, B.S). Co-mentoring research projects and MS Researchers.

🏆 Awards/Achievements

Editorial board member, Science Journal of Chemistry. Associate Editor, Frontiers in Chemistry. Excellent student award, Beijing Institute of Technology, China (2020). Chinese Government Scholarship (CGS) award, Chinese Government Scholarship Council (2016). PEEF scholarship award, Punjab Education Endowment Fund, Pakistan (2012).

🔧 Organizational Skills

Project management (participated in NSFC project). Time management (meets deadlines consistently). Scheduling (organized desk with a paper-filing system). Task Analysis & Planning (effective organization of big tasks into small steps).

🔍 Ph.D. Researcher (Sept. 2016 – June 2021)

Participated in NSFC Project on designing the interface between sulfide electrolyte and high specific energy cathode in all-solid-state lithium batteries. Developed mechanisms for air stability of sulfide solid electrolytes using ex-situ XRD, XPS, NMR, SEM. Implemented strategies to improve active mass utilization in all-solid-state batteries. Authored progress reports and publications for Research & Development grant.

👨‍🔬 Junior Research Fellow (Sept. 2014 – July 2016)

Worked on the synthesis and characterization of polymers using different polymerization techniques. Synthesized di-, tri-block copolymeric architectures via radical (ATRP) and ring-opening polymerization techniques. Developed comprehensive analytical methods for di, tri-block copolymers using GPC, SEC, and Advanced LCCC methods.

👨‍🏫 Lecturer of Chemistry (CTI) – Oct. 2013 – Jun. 2014

Taught courses in Inorganic, Analytical, and Applied Chemistry. Served as Laboratory In-Charge.

🖥 Digital Skills

Computational Chemistry.
Chemdraw3D.
Materials Studio.
Diamond.
VESTA.
Origin.
Microsoft Word.
Presentation designing skills.

💼 Professional Skills

Interpretation of different NMR spectra (H, C, Li, and P). Operation and interpretation of XRD, XPS, Raman, SEM, and TEM. Practical experience on the electrochemical workstation and Battery performance machine. Trained in operating different chromatographic techniques such as HPLC, GPC, SEC, and Advanced LCCC. Interpretation of different mass spectrometry (EI, MALDI, TOP-SIMS).

📚Top Noted Publication

“Synthesis of visible-light-responsive lanthanum-doped copper ferrite/graphitic carbon nitride composites for the photocatalytic degradation of toxic organic pollutants.”
- Authors: Ahmed, Adeel, Rusul Alabada, Muhammad Usman, Asma A. Alothman, Muhammad Khurram Tufail*, Saikh Mohammad, and Zubair Ahmad.
- Journal: Diamond and Related Materials 141 (2024): 110630.
- Role: Corresponding Author.
- Impact Factor (I.F): 4.1
“Designing efficient materials for high-performance organic solar cells: Detailed chemical space exploration, machine learning and virtual screening.”
- Authors: Muhammad Khurram Tufail*, Syed Shoaib Ahmad Shah, Salahuddin Khan, Farooq Ahmad, Lucy W. Kiruri, Misbah Sehar Abbasi, and Ali Ahmad.
- Journal: Chemical Physics Letters 834 (2024): 140974.
- Role: Corresponding Author.
- Impact Factor (I.F): 2.8
“Design of Solid Electrolytes with Fast Ion Transport: Computation-driven and Practical Approaches”.
- Authors: Muhammad Khurram Tufail, Pengbo Zhai, Mengyang Jia, Ning Zhao*, Xiangxin Guo*.
- Journal: Energy Materials Advances, (2023), 4,0015.
- Role: First Author.
- Impact Factor (I.F): 12.9
“Evaluation of Solid Electrolytes: Development of Conventional and Interdisciplinary Approaches”.
- Authors: Muhammad Khurram Tufail, Pengbo Zhai, Waquar Khokar, Mengyang Jia, Ning Zhao*, Xiangxin Guo*.
- Journal: Interdisciplinary Materials; (2023) 2.12112.
- Role: First Author.
“Combination of 3D current collectors and in situ polymerized electrolytes enabling high-mass-loading cathodes for solid-state lithium batteries”.
- Authors: Qifu Sun, Muhammad Khurram Tufail, Wenkai Li, Ning Zhao, Zhijie Bi, Xiangxin Guo*.
- Journal: Applied Physics Letters; (2023), 21390.
- Role: Second Author.
- Impact Factor (I.F): 3.9
“Insight into the key factors in high Li+ transference number composite electrolytes for solid lithium batteries”.
- Authors: Mengyang Jia, Muhammad Khurram Tufail, Xiangxin Guo*.
- Journal: ChemSusChem; (2023).
- Role: Second Author.
- Impact Factor (I.F): 9.1
“Chemistry Aspects and Designing Strategies of Flexible Materials for High-performance Flexible Lithium-Ion Batteries”.
- Authors: Muhammad Khurram Tufail, Adeel Ahmed, Muhammad Rafiq, Muhammad Asif Nawaz, Syed Shoaib Ahmad Shah, Manzar Sohail, Tayyaba Najam, Mohammed M. Rahman.
- Journal: The Chemical Records; (2023), 202300155.
- Role: First Author.
- Impact Factor (I.F): 6.9
“Selective capture of uranium and zirconium from strong HNO3 solution by ethenylphosphonic acid copolymerized polymer.”
- Authors: Muhammad Hammad ul Haq,, Xu Zhang, Fengqi Zhang, Alemtsehay Tesfay Reda, Dongxiang Zhang, Muhammad Zahid, Muhammad Khurram Tufail et al.
- Journal: Chemical Engineering Journal 476 (2023): 146674.
- Impact Factor (I.F): 15.5
“Synthesis of Electrical Conductive Metal‐Organic Frameworks for Electrochemical Applications.”
- Authors: Shoaib Ahmad Shah, Syed, Muhammad Altaf Nazir, Azhar Mahmood, Manzar Sohail, Aziz ur Rehman, Muhammad Khurram Tufail, Tayyaba Najam et al.
- Journal: The Chemical Record (2023): e202300141.
- Impact Factor (I.F): 6.9
“Ansa-metallocene catalyst based on 3-phenyl and 4-methyl substituted: catalyst evaluation in conjugated and nonconjugated diene polymerization.”
- Authors: Ali, Amjad, Muhammad Nadeem, Ahmad Naveed, Tariq Aziz, Muhammad Khurram Tufail, Jamile Mohammadi Moradian, Naushad Ahmad et al.
- Journal: Journal of Polymer Research 30, no. 8 (2023): 318.
- Impact Factor (I.F): 2.8

Andrea Mayado | Immunology | Women Researcher Award

Published on 09/02/2024 by Young Scientists Awards

Dr. Andrea Mayado | Immunology | Women Researcher Award

Professional Profile 🌟

I am Andrea Mayado Colino, a Spanish researcher with a strong background in pharmacy. I earned my Bachelor’s degree in Pharmacy from the University of Salamanca in 2006, followed by a Master’s degree and Ph.D. at the Complutense University of Madrid in 2011. My doctoral thesis focused on the involvement of interleukin-1 beta in the preconditioning against neurotoxicity caused by 3,4-methylenedioxymethamphetamine (MDMA) in the rat brain. Throughout my Ph.D., I was awarded a 4-year “Formación de Profesorado Universitario (FPU)” fellowship from the Ministry of Education, Culture, and Sport. Currently, I am a member of the Mastocytosis research team and conduct my research at the Cancer Research Center. I completed my second post-doc at the University of Twente (The Netherlands) in 2018, specializing in early detection of Pancreatic Ductal Adenocarcinoma through liquid biopsy. I have actively participated in 18 competitive financing projects and have a prolific scientific production with 41 publications in top-tier international journals in biomedicine and pharmacology. My cumulative Impact Factor exceeds 330 in the last 5 years, and I hold an H index of 19.

Professional Profiles

🧪General Quality Indicators of Scientific Research

Total Publications: 41, Publications in First Decile: 19, Publications in First Quartile: 12, First Author Publications: 6, Senior Author Publications: 2, Cumulative Impact Factor: 330.956, H Index: 19, Participation in 18 R&D Projects

Current Professional Situation

Employing Entity: Centro de Investigación Biomédica en Red: Cáncer, Professional Category: Investigador posdoctoral (Postdoctoral Researcher), Start Date: 06/04/2023, Type of Contract: Permanent Employment Contract, Dedication Regime: Full Time

Previous Positions and Activities

Various postdoctoral positions in prestigious research institutions.
Research tasks focused on cellular biology, proteomics, hematological oncology, and systemic mastocytosis.

Education

Bachelor’s in Pharmacy, University of Salamanca (2006)
Ph.D. in Pharmacology and Human Therapeutics, Complutense University of Madrid (2011)

Teaching Experience

Practical courses in Immunology and Pharmacology, University of Salamanca.

Other Activities

Membership in the Spanish Network of Mastocytosis (REMA) and the European Competence Network on Mastocytosis. Participation in various research and biomedical information courses. 🌍

Scientific or Technological Activities – R&D Projects

Project: Modulation of the immune response in systemic mastocytosis: role of the cell microenvironment and potential association with the clinical evolution of the disease (PI19/01166) Entity: Proyectos de Investigación en Salud (AES 2019). Modalidad proyectos en salud. Centro de Investigación del Cáncer City: Salamanca, Castile and León, Spain Principal Investigator: García-Montero AC Number of Researchers: 5 Type of Participation: Team member Project: Minimally-invasive blood-based diagnostic tools for early detection of pancreatic cancer. Detección de células circulantes tumorales en muestras de biopsia líquida como herramienta diagnóstica del adenocarcinoma ductal de páncreas GRS 2041/A/19 Entity: Gerencia Regional de Salud. Junta de Castilla y León. City: Salamanca, Castile and León, Spain Principal Investigator: Muñoz-Bellvis L Number of Researchers: 9 Type of Participation: Team member Start-End Date: 01/01/2020 – 31/12/2020 Project: Diseño y validación de un algoritmo genético para predecir la transformación maligna de mastocitosis indolentes a formas agresivas y otras hemopatías malignas. Design and validation of a genetic algorithm to predict malignant transformation from indolent forms to aggressive forms of systemic mastocytosis. Entity: Proyectos de Investigación en Salud. Instituto de Salud Carlos. Centro de Investigación del Cáncer. Institute of Health Carlos III. Cancer Research Institute. Type of Participation: Team member Start-End Date: 2016 – 31/12/2018